Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Biotechnology

Volume 21, 15 Issues, 2020
ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
This journal supports open access

Ranking and Category

  • 259th of 298 in

    Biochemistry & Molecular Biology

  • 219th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Current Pharmaceutical Biotechnology, Volume 1 - Number 1


Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma

, 1(1): 1 - 9

A. J. Grillo-Lopez, C. A. White, B. K. Dallaire, C. L. Varns, C. D. Shen, A. Wei, J. E. Leonard, A. McClure, R. Weaver, S. Cairelli and J. Rosenberg


DOI: 10.2174/1389201003379059









Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases

, 1(1): 107 - 116

Ignacio Perez-Roger, Carmen Ivorra, Antonio Diez, Maria Jose Cortes, Enric Poch, Silvia M. Sanz-Gonzalez and Vicente Andres


DOI: 10.2174/1389201010001010107




Editor-in-Chief

Nikolaos Labrou
Department of Biotechnology
Agricultural University of Athens
Athens
Greece

Biography View Full Editorial Board

Journal History

Current Pharmaceutical Biotechnology was launched in 2000. Dr. Nikolaos Labrou serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.97

Advertisement

Coronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog